BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 18039120)

  • 1. Spectrum of Epstein-Barr virus-associated diseases.
    Kutok JL; Wang F
    Annu Rev Pathol; 2006; 1():375-404. PubMed ID: 18039120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease.
    Shimoyama Y; Yamamoto K; Asano N; Oyama T; Kinoshita T; Nakamura S
    Cancer Sci; 2008 Jun; 99(6):1085-91. PubMed ID: 18429953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma Protein Is Required for Epstein-Barr Virus Replication in Differentiated Epithelia.
    Myers JE; Schaal DL; Nkadi EH; Ward BJH; Bienkowska-Haba M; Sapp M; Bodily JM; Scott RS
    J Virol; 2023 Feb; 97(2):e0103222. PubMed ID: 36719239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi.
    Westmoreland KD; Montgomery ND; Stanley CC; El-Mallawany NK; Wasswa P; van der Gronde T; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Kampani C; Liomba NG; Tomoka T; Dhungel BM; Sanders MK; Krysiak R; Kazembe P; Dittmer DP; Fedoriw Y; Gopal S
    Int J Cancer; 2017 Jun; 140(11):2509-2516. PubMed ID: 28268254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raman spectroscopy of lymphocytes from patients with the Epstein-Barr virus infection.
    Pietruszewska M; Biesiada G; Czepiel J; Birczyńska-Zych M; Moskal P; Garlicki A; Wesełucha-Birczyńska A
    Sci Rep; 2024 Mar; 14(1):6417. PubMed ID: 38494496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 induces lytic reactivation of EBV through PGE2 by modulating the EP receptor signaling pathway.
    Gandhi J; Gaur N; Khera L; Kaul R; Robertson ES
    Virology; 2015 Oct; 484():1-14. PubMed ID: 26057147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and lymphoma.
    Grogg KL; Miller RF; Dogan A
    J Clin Pathol; 2007 Dec; 60(12):1365-72. PubMed ID: 18042692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone methylation in Epstein-Barr virus-associated diseases.
    Chen G; Zhang L; Wang R; Xie Z
    Epigenomics; 2024 May; ():1-13. PubMed ID: 38869454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection.
    Okano M; Gross TG
    Am J Med Sci; 2012 Jun; 343(6):483-9. PubMed ID: 22104426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and problems in understanding and managing primary Epstein-Barr virus infections.
    Odumade OA; Hogquist KA; Balfour HH
    Clin Microbiol Rev; 2011 Jan; 24(1):193-209. PubMed ID: 21233512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of Epstein-Barr virus persistent infection.
    Thorley-Lawson DA; Hawkins JB; Tracy SI; Shapiro M
    Curr Opin Virol; 2013 Jun; 3(3):227-32. PubMed ID: 23683686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of Epstein-Barr virus-related diseases: a pictorial review.
    Maeda E; Akahane M; Kiryu S; Kato N; Yoshikawa T; Hayashi N; Aoki S; Minami M; Uozaki H; Fukayama M; Ohtomo K
    Jpn J Radiol; 2009 Jan; 27(1):4-19. PubMed ID: 19373526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis.
    Ali AS; Al-Shraim M; Al-Hakami AM; Jones IM
    Open Virol J; 2015; 9():7-28. PubMed ID: 26862355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated lymphoproliferative disorders.
    Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
    Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why and How Epstein-Barr Virus Was Discovered 50 Years Ago.
    Epstein A
    Curr Top Microbiol Immunol; 2015; 390(Pt 1):3-15. PubMed ID: 26424640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantation.
    Xuan L; Jiang X; Sun J; Zhang Y; Huang F; Fan Z; Guo X; Dai M; Liu C; Yu G; Zhang X; Wu M; Huang X; Liu Q
    Transplantation; 2013 Sep; 96(6):560-6. PubMed ID: 23842192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-associated lymphoproliferative disorders: classification and treatment.
    Carbone A; Gloghini A; Dotti G
    Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.
    Hatton OL; Harris-Arnold A; Schaffert S; Krams SM; Martinez OM
    Immunol Res; 2014 May; 58(2-3):268-76. PubMed ID: 24619311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis.
    Münz C
    Nat Rev Microbiol; 2019 Nov; 17(11):691-700. PubMed ID: 31477887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host genetics of Epstein-Barr virus infection, latency and disease.
    Houldcroft CJ; Kellam P
    Rev Med Virol; 2015 Mar; 25(2):71-84. PubMed ID: 25430668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.